FDA CONTINUES TO ASSESS NEOPLASIA RISKS, INCLUDING MALIGNANCY, IN SIMILAR AAV GENE THERAPY PROGRAMS
Türkçe
FDA, BENZER AAV GEN TERAPİSİ PROGRAMLARINDA NEOPLAZİ RİSKLERİNİ, MALİGNİTE DAHİL, DEĞERLENDİRMEYE DEVAM EDİYOR.
Breaking crypto & TradFi news, the moment it happens